205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
43.35%
Net income growth 1.25-1.5x ADI's 30.77%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.25%
Negative yoy while ADI is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
42.40%
Operating cash flow growth similar to ADI's 44.35%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-0.40%
Both yoy lines negative, with ADI at -11.38%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-57.29%
Negative yoy purchasing while ADI stands at 53.66%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-47.33%
Both yoy lines are negative, with ADI at -48.52%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-337.54%
Both yoy lines negative, with ADI at -305.26%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
23.68%
Stock issuance far above ADI's 18.75%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
16.57%
Buyback growth of 16.57% while ADI is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.